Overview
Neurelis, Inc. is a biopharmaceutical company specializing in the development and manufacturing of FDA-approved therapies for neurological conditions, particularly epilepsy treatments, utilizing its proprietary drug stabilization and Intravail technology platforms. The company focuses on advancing pharmaceutical manufacturing and drug development to deliver innovative solutions for patients with neurological disorders.
More in Neurotechnology
Latest industry news
It's Finally Here: FacialDx, an AI-Powered Support Tool for Sideline Concussion Assessments
2026-06-23 · Product
MIT Researchers Demonstrate Real-Time Emotion Decoding via Non-Invasive EEG with 94% Accuracy
2026-06-13 · Research
Synchron Launches Stentrode Home Edition, Expanding BCI Access Beyond Clinical Settings
2026-06-11 · Product
Synchron Reaches 100-Patient Milestone as Stentrode BCI Moves Toward Pivotal Trial
2026-06-09 · Industry
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →